Literature DB >> 9696931

Expression of p53, bcl-2 and heat shock protein (hsp72) in malignant and benign ovarian tumours.

P Athanassiadou1, E Petrakakou, V Sakelariou, C Zerva, A Liossi, S Michalas, P Athanassiades.   

Abstract

The occurrence of p53, bcl-2 and heat shock protein (HSP) expression in ovarian tumours was examined and the correlation was investigated between the expression of these proteins and other disease parameters, including FIGO stage, histological subtype, tumour differentiation and steroid hormone receptor status. We analysed p53, bcl-2 and HSP expression in 100 smears of patients with epithelial ovarian carcinomas, 16 smears of patients with borderline malignancy and 20 smears of patients with benign ovarian neoplasms by using immunocytochemical techniques. There were 29 patients with stage I disease, 24 with stage II disease, 40 with stage III disease and seven with stage IV disease according to the FIGO classification. The sensitivities and specificities of bcl-2, p53 and HSP for malignancy were 53% and 40%, 43% and 80%, and 37% and 90%, respectively. HSP was statistically significantly associated with malignant rather than benign tumours. Significant association was also observed between bcl-2 and p53, and p53 and HSP. The association of HSP with malignant tumours is confined to the premenopausal group of patients and in this group by itself there is also a significant association between p53 and malignancy. HSP and p53 were associated with undifferentiated carcinomas, bcl-2 and p53 expression is reduced as disease stage progresses in serous carcinomas and bcl-2 expression is increased as disease progresses in endometrioid carcinomas. There was no significant association between bcl-2 and ER/PR status. In conclusion, HSP has a high specificity for malignant ovarian tumours, bcl-2 and p53 have only moderate to low sensitivity and specificity. Changes in the frequency of bcl-2 and p53 overexpression between FIGO I and FIGO III stage disease of different ovarian carcinomas indicate a different role of these substances in cellular survival mechanisms in different carcinomas. bcl-2 probably is associated with cell proliferation but not with differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696931     DOI: 10.1097/00008469-199806000-00007

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  9 in total

Review 1.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

2.  TRAIL-induced apoptosis is enhanced by heat shock protein 70 expression.

Authors:  N J Clemons; R L Anderson
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

Review 3.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications.

Authors:  Daniel R Ciocca; Stuart K Calderwood
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

4.  Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours.

Authors:  Raffaèle Fauvet; Christophe Poncelet; Danièle Hugol; Anne Lavaur; Gérard Feldmann; Emile Daraï
Journal:  Virchows Arch       Date:  2003-05-20       Impact factor: 4.064

Review 5.  The HSP70 family and cancer.

Authors:  Maureen E Murphy
Journal:  Carcinogenesis       Date:  2013-04-04       Impact factor: 4.944

Review 6.  Heat shock proteins at the crossroads between cancer and Alzheimer's disease.

Authors:  Hao Wang; Meng-Shan Tan; Rui-Chun Lu; Jin-Tai Yu; Lan Tan
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

7.  CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis.

Authors:  Jihye Jang; Mi Ra Kim; Taek-Keun Kim; Woo Ran Lee; Jong Heon Kim; Kyun Heo; Sukmook Lee
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

8.  ARHGEF10L Promotes Cervical Tumorigenesis via RhoA-Mediated Signaling.

Authors:  Junyi Tang; Kehua Fang; Chang Li; Xiaotian Chang
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-24       Impact factor: 2.629

9.  The expression of FAS-associated factor 1 and heat shock protein 70 in ovarian cancer.

Authors:  Hye-Ju Kang; Hye-Sung Moon; Hye-Won Chung
Journal:  Obstet Gynecol Sci       Date:  2014-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.